Inside Pediatrics

Sickle Cell Disease - Treatments, Advances and Cures

Jeffrey Lebensburger, DO, MSPH - Speaker Bio
Jeffrey Lebensburger DO, MSPH, earned his undergraduate degree from the University of Pennsylvania, medical degree from Nova Southeastern College of Osteopathic Medicine and master’s degree in clinical and translational science from the University of Alabama at Birmingham (UAB) School of Public Health. Dr. Lebensburger is a board-certified pediatrician and pediatric hematologist-oncologist. He is director of the Pediatric Hematology Section in the UAB Division of Pediatric Hematology and Oncology. He has published more than 50 manuscripts and has received several prestigious grants from the National Institutes of Health (NIH), multiple societies and industries for research. On a national level, Dr. Lebensburger serves as an invited expert for the development of the American Society of Hematology (ASH) Sickle Cell Guidelines, FDA/ASH Sickle Cell Clinical Trial Endpoints, NIH Cure Sickle Cell Initiative and the ASH Sickle Cell Clinical Trials Network.
  • Topic Info:September is Childhood Cancer and Sickle Cell Awareness Month. In this episode of the Inside Pediatrics Podcast, Dr. Jeff Lebensburger shares an update on sickle cell disease – early detection and treatment, bone marrow transplants, current pain therapy and promising research for a cure within the first few months of life.